Kaliumlosartan Sandoz

Losartan potassium, the active ingredient in Kaliumlosartan Sandoz, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension and related cardiovascular conditions in adults.

GNH USA supplies Kaliumlosartan Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaliumlosartan Sandoz is an angiotensin II receptor blocker used in several cardiovascular and renal disease pathways. - Hypertension: lowers blood pressure by reducing vascular resistance. - Heart failure: improves symptoms and reduces hospitalisation risk. - Diabetic nephropathy: slows progression of kidney damage in patients with diabetes.

Losartan potassium may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: especially after the first dose or dose increase. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Nasal congestion: occasional blockage of nasal passages. - Diarrhoea: loose stools without blood. - Muscle cramps: transient tightening of skeletal muscles.

Serious or Rare Side Effects: - Hyperkalemia: elevated potassium levels that may affect heart rhythm. - Acute kidney injury: sudden decline in renal function. - Angio‑edema: swelling of face, lips, tongue or throat. - Hepatic injury: abnormal liver enzyme elevations. - Severe hypotension: markedly low blood pressure causing faintness. - Allergic reactions: rash, itching or hives.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Renal function: assess baseline creatinine and eGFR, adjust if impaired. - Electrolytes: monitor potassium levels, especially with concomitant potassium‑sparing agents. - Pregnancy: avoid use; teratogenic risk is not established. - Drug interactions: review concurrent medications for major interactions. - Elderly patients: start with lower dose and titrate cautiously. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and direct sunlight.

Losartan potassium can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): combined use may increase renal risk. - Potassium‑sparing diuretics or supplements: may cause dangerous hyperkalemia. - ACE inhibitors: concurrent use can lead to additive hypotension and renal dysfunction.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce antihypertensive effect and impair renal function. - Lithium: losartan can increase lithium levels, risking toxicity. - Rifampin or other CYP inducers: may lower losartan plasma concentrations.